Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL28140423 | 0.90 | CYP1A2 (0.51) | CYP1A2CA1CA9CYP2D6ALPG | |
| Methacrylic Acid SCHEMBL6282496 | 0.84 | CYP1A2 (0.41) | CYP1A2CA1CA9 | |
| SCHEMBL28064716 | 0.84 | CYP1A2 (0.60) | CYP1A2CA1CA9CYP2D6ALPG | |
| SCHEMBL36360 | 0.84 | — | — | |
| SCHEMBL9608918 | 0.84 | — | — | |
| SCHEMBL14144051 | 0.84 | — | — | |
| Acrylic Acid SCHEMBL28833696 | 0.83 | CYP1A2 (0.46) | CYP1A2CA1CA9CYP2D6ALPG | |
| Arsenic SCHEMBL28143249 | 0.82 | — | — | |
| Methane SCHEMBL28076377 | 0.82 | — | — | |
| Ethylene Glycol SCHEMBL28196636 | 0.80 | CYP1A2 (0.53) | CYP1A2CA1CA9CYP2D6ALPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079828-B2 | Polymerizable compounds comprising a polyalicylic structure element | VOCO GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-9023916-B2 | Composite material comprising a monomer with a polyalicyclic structure element | VOCO GMBH (DE) | 2015-05-05 | — | — | US | disclosed |
| US-8979535-B2 | Compositions for infiltration and/or sealing of hard tooth tissue and corresponding methods | VOCO GMBH (DE) | 2015-03-17 | — | — | US | disclosed |
| US-8915736-B2 | Composition comprising a monomer with a polyalicyclic structure element for filling and/or sealing a root canal | VOCO GMBH (DE) | 2014-12-23 | — | — | US | disclosed |
| US-8697769-B2 | Lacquer composition comprising a monomer with a polyalicyclic structure element | VOCO GMBH (DE) | 2014-04-15 | — | — | US | disclosed |
| US-8669302-B2 | Composite material comprising a monomer with a polyalicyclic structure element as a sealing material | VOCO GMBH (DE) | 2014-03-11 | — | — | US | disclosed |
| US-20120083550-A1 | Composite Material Comprising a Monomer with a Polyalicyclic Structure Element as a Sealing Material | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120082958-A1 | Composite Material Comprising a Monomer with a Polyalicyclic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120082954-A1 | Composition Comprising a Monomer with a Polyalicyclic Structure Element for Filling and/or Sealing a Root Canal | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120082637-A1 | Lacquer Composition Comprising a Monomer with a Polyalicyclic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082958-A1 | Composite Material Comprising a Monomer with a Polyalicyclic Structure Element | INTS9, PARG, SMCHD1 | CYP1A2 2789/4885CA1 1312/4885CA9 1873/4885 |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | PCBP1, PUF60, PARG | CYP1A2 4416/4885CA1 532/4885CA9 801/4885 |
| US-20120082637-A1 | Lacquer Composition Comprising a Monomer with a Polyalicyclic Structure Element | PELP1, ERCC1, GLRA1 | CYP1A2 4667/4885CA1 154/4885CA9 890/4885 |
| US-20120083550-A1 | Composite Material Comprising a Monomer with a Polyalicyclic Structure Element as a Sealing Material | ERCC1, PARG, EPN1 | CYP1A2 4269/4885CA1 2158/4885CA9 3370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.